share_log

12 Information Technology Stocks Moving In Tuesday's After-Market Session

Benzinga ·  Apr 23 16:31

Gainers

  • XIAO-I (NASDAQ:AIXI) stock moved upwards by 8.9% to $1.47 during Tuesday's after-market session. The market value of their outstanding shares is at $105.9 million.
  • AudioEye (NASDAQ:AEYE) stock increased by 7.27% to $14.46. The company's market cap stands at $168.5 million. The company's, Q1 earnings came out today.
  • Texas Instruments (NASDAQ:TXN) stock increased by 5.72% to $174.94. The market value of their outstanding shares is at $159.2 billion. As per the press release, Q1 earnings came out today.
  • Tungray Technologies (NASDAQ:TRSG) stock rose 4.2% to $5.95. The company's market cap stands at $27.1 million.
  • Blend Labs (NYSE:BLND) stock rose 4.02% to $2.58. The market value of their outstanding shares is at $650.2 million.
  • BTCS (NASDAQ:BTCS) shares increased by 3.88% to $1.59. The company's market cap stands at $24.9 million.

Losers

  • Enphase Energy (NASDAQ:ENPH) stock decreased by 9.6% to $102.55 during Tuesday's after-market session. The market value of their outstanding shares is at $13.9 billion. The company's, Q1 earnings came out today.
  • Baijiayun Group (NASDAQ:RTC) shares fell 8.2% to $1.12. The company's market cap stands at $98.2 million.
  • Manhattan Associates (NASDAQ:MANH) shares declined by 7.0% to $214.5. The company's market cap stands at $13.2 billion. The company's, Q1 earnings came out today.
  • Rubicon Technologies (NYSE:RBT) stock declined by 6.62% to $0.34. The market value of their outstanding shares is at $17.9 million.
  • Mawson Infra Gr (NASDAQ:MIGI) stock declined by 5.97% to $1.42. The company's market cap stands at $23.6 million.
  • Core Scientific (NASDAQ:CORZ) stock fell 4.47% to $3.34. The market value of their outstanding shares is at $618.5 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment